FI925745A7 - Interleukiini-6-koostumuksia ja menetelmä niiden valmistamiseksi - Google Patents

Interleukiini-6-koostumuksia ja menetelmä niiden valmistamiseksi Download PDF

Info

Publication number
FI925745A7
FI925745A7 FI925745A FI925745A FI925745A7 FI 925745 A7 FI925745 A7 FI 925745A7 FI 925745 A FI925745 A FI 925745A FI 925745 A FI925745 A FI 925745A FI 925745 A7 FI925745 A7 FI 925745A7
Authority
FI
Finland
Prior art keywords
interleukin
compositions
preparing
Prior art date
Application number
FI925745A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI925745L (fi
FI925745A0 (fi
Inventor
Shingou Sakurai
Masanobu Naruto
Makoto Kihara
Keizo Hanada
Emiko Sano
Shigeru Ichikura
Jun Utsumi
Kazuo Hosoi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of FI925745L publication Critical patent/FI925745L/fi
Publication of FI925745A7 publication Critical patent/FI925745A7/fi
Publication of FI925745A0 publication Critical patent/FI925745A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI925745A 1991-04-18 1992-04-17 Interleukin-6-kompositioner och foerfarande foer deras framstaellning FI925745A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8660291 1991-04-18
JP8828491 1991-04-19
PCT/JP1992/000487 WO1992018537A1 (en) 1991-04-18 1992-04-17 Interleukin 6 composition and production thereof

Publications (3)

Publication Number Publication Date
FI925745L FI925745L (fi) 1992-12-17
FI925745A7 true FI925745A7 (fi) 1992-12-17
FI925745A0 FI925745A0 (fi) 1992-12-17

Family

ID=26427716

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925745A FI925745A0 (fi) 1991-04-18 1992-04-17 Interleukin-6-kompositioner och foerfarande foer deras framstaellning

Country Status (10)

Country Link
EP (1) EP0550756B1 (enExample)
KR (1) KR930700550A (enExample)
AT (1) ATE210150T1 (enExample)
AU (1) AU1554592A (enExample)
CA (1) CA2085744A1 (enExample)
DE (1) DE69232259T2 (enExample)
ES (1) ES2164050T3 (enExample)
FI (1) FI925745A0 (enExample)
TW (1) TW221379B (enExample)
WO (1) WO1992018537A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
AU2051899A (en) 1997-12-03 1999-06-16 Roche Diagnostics Gmbh Method for preparing polypeptides with appropriate glycosilation
IL143641A0 (en) 1998-12-09 2002-04-21 A method for manufacturing glycoproteins having human-type glycosylation
DE60035285T2 (de) 1999-10-26 2008-02-21 Plant Research International B.V. Glykolisierung des säugetiertyps in pflanzen
WO2002057468A2 (en) 2001-01-19 2002-07-25 The Dow Chemical Company Method for secretory production of glycoprotein having human-type sugar chain using plant cell
JP4532118B2 (ja) 2002-03-19 2010-08-25 スティヒティング ディーンスト ランドバウクンディフ オンデルズーク 植物体内のグリカンプロセシングの最適化
EP2319934B1 (en) 2002-03-19 2015-09-02 Stichting Dienst Landbouwkundig Onderzoek GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants.
CL2003002461A1 (es) 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
EP2535418B1 (en) 2007-04-17 2016-03-30 Stichting Dienst Landbouwkundig Onderzoek Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6062997A (ja) * 1983-09-17 1985-04-11 Mochida Pharmaceut Co Ltd インタ−フエロンの生産方法
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
JPS62153755A (ja) * 1985-12-27 1987-07-08 Showa Denko Kk クロマトグラフイ−用吸着担体
JP2648860B2 (ja) * 1986-05-08 1997-09-03 イエダ リサーチ アンド デベロップメント コンパニー リミテッド ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
JP2676336B2 (ja) * 1986-08-06 1997-11-12 忠三 岸本 ヒトｂ細胞分化因子の遺伝子
JPS63150297A (ja) * 1986-12-12 1988-06-22 Ajinomoto Co Inc 新規ｂ細胞分化因子蛋白標品
ATE112308T1 (de) * 1987-10-13 1994-10-15 Thomae Gmbh Dr K Verfahren zur herstellung von proteinen.
JPH03133935A (ja) * 1989-10-19 1991-06-07 Toray Ind Inc ヒト天然型インターロイキン６組成物

Also Published As

Publication number Publication date
DE69232259T2 (de) 2002-06-13
FI925745L (fi) 1992-12-17
AU1554592A (en) 1992-11-17
ES2164050T3 (es) 2002-02-16
FI925745A0 (fi) 1992-12-17
WO1992018537A1 (en) 1992-10-29
TW221379B (enExample) 1994-03-01
DE69232259D1 (de) 2002-01-17
KR930700550A (ko) 1993-03-15
CA2085744A1 (en) 1992-10-19
EP0550756B1 (en) 2001-12-05
EP0550756A1 (en) 1993-07-14
ATE210150T1 (de) 2001-12-15
EP0550756A4 (enExample) 1994-04-27

Similar Documents

Publication Publication Date Title
FI903440A7 (fi) Stabiloidut FGF-koostumukset ja menetelmä niiden valmistamiseksi
FI933357A7 (fi) Menetelmä benzamidien valmistamiseksi
FI895075A7 (fi) Synergistiset makeuttamiskoostumukset ja menetelmä niiden valmistamiseksi
FI922969A7 (fi) Menetelmiä ja koostumuksia hapen poistamiseksi
FI905300A7 (fi) Menetelmä ja valmiste joissa käytetään tyyppiä II olevaa endoglykosidaasia
FI910625A7 (fi) Syötävä päällystetty koostumus ja menetelmä sen valmistamiseksi
FI934926A7 (fi) Adsorbenttikoostumuksia ja menetelmiä niiden valmistamiseksi
FI942937L (fi) Huokoisia muotoiltuja antovälineitä ja menetelmä niiden valmistamiseksi
FI921609A7 (fi) Menetelmiä ja koostumuksia luun parantamiseksi
MX174001B (es) Composiciones cementicias y metodo
FI931940A7 (fi) Koostumuksia ja menetelmiä liuoksen identifioimiseksi
FI934141A7 (fi) Antikoagulantit ja menetelmiä niiden valmistamiseksi
FI930076A7 (fi) Systeamiinia sisältävä permanenttauskoostumus ja menetelmä
FI891145L (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
FI922473A7 (fi) Elintarvikkeen modifioija ja menetelmä tämän valmistamiseksi
FI924051A7 (fi) Menetelmä keskitisleiden valmistamiseksi
FI942932A7 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI940775L (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI925745A7 (fi) Interleukiini-6-koostumuksia ja menetelmä niiden valmistamiseksi
FI885942L (fi) Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi
FI950713L (fi) Mallipastakokoomus ja menetelmä sen valmistamiseksi
FI933359A7 (fi) Rehun lisäaine ja menetelmä
FI906013A7 (fi) Parkettirakenne ja menetelmä sen valmistamiseksi
FI933642A7 (fi) Koostumus ja menetelmiä luun muodostamiseksi
FI934395A7 (fi) 2-spirosyklopropyyli 4-asyylicephemi sekä menetelmä sen valmistamiseks i

Legal Events

Date Code Title Description
FD Application lapsed